Article and Video CATEGORIES
For our first video in this month of gratitude, Linnea Olson stepped in front of the camera. Linnea is one of many of our dedicated and amazing GRACE community who works hard as the best kind of patient advocate. Helping others to learn about lung cancer helps us all. We hold Linnea in the highest regard and are so grateful she shared herself with us for this Lung Cancer Awareness Month campaign.
Don't forget to check out our social media – GRACE's Twitter, Facebook, YouTube, and Instagram feeds – and be sure to follow us on at least one of those platforms, where we hope you'll also share your own photos or thoughts on gratitude.
Keep checking in to see the newest information about lung cancer treatments. We encourage you to share GRACE with the lung cancer patients and caregivers in your life so that they can benefit as well.
We would like to thank Keith Singer at Catch It in Time, who produced the videos, to Gilles Frydman and Laya Dogmetchi who took the portraits you will see throughout the month, to the patients and caregivers who stepped in front of our cameras with open and grateful hearts, and to you, the people who visit the GRACE website and read our materials on a regular basis. Thank you for appreciating our work.
And thanks to the following companies for their support of our LCAM 2016 program
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…